IP Library Granted Patent US 7,157,554
Granted Patent B2
US 7,157,554 · App. 11/080,130 · Granted Jan 2, 2007

Glycopeptide carboxy-saccharide derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,157,554
App. No.
11/080,130
Granted
Jan 2, 2007
Kind
B2
Abstract

Disclosed are glycopeptide derivatives substituted at the C-terminus and/or the R-terminus with a substituent that comprises one or more saccharide groups and a carboxy group; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

Claims (24)

1. A method of modifying a glycopeptide antibiotic to form a glycopeptide antibiotic derivative having reduced tissue accumulation when administered to a mammal, the method comprising forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent comprising a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide.

2. The method of claim 1 , wherein the glycopeptide antibiotic is vancomycin or a derivative thereof.

3. The method of claim 1 , wherein the glycopeptide antibiotic is chloroorienticin A or a derivative thereof.

4. The method of claim 1 , wherein the glycopeptide antibiotic is teicoplanin or a derivative thereof.

5. The method of claim 1 , wherein the substituent is a substituent of formula III:

wherein one of R g and R h is a saccharide, and the other of R g and R h is OH.

6. The method of claim 1 , wherein the substituent is a substituent of formula IV:

wherein one of R m and R n is a saccharide, and the other is OH.

7. The method of claim 1 , wherein the substituent is a substituent of formula (i):

8. The method of claim 1 , wherein the substituent is a substituent of formula (ii):

9. The method of claim 1 , wherein the substituent is a substituent of formula (iii):

10. The method of claim 1 , wherein the substituent is a substituent of formula (iv):

11. A method of modifying a glycopeptide antibiotic to farm a glycopeptide antibiotic derivative having increased urinary clearance when administered to a mammal, the method comprising forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent comprising a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide.

12. The method of claim 11 , wherein the glycopeptide antibiotic is vancomycin or a derivative thereof.

13. The method of claim 11 , wherein the glycopeptide antibiotic is chloroorienticin A or a derivative thereof.

14. The method of claim 11 , wherein the glycopeptide antibiotic is teicoplanin or a derivative thereof.

15. The method of claim 11 , wherein the substituent is a substituent of formula III:

wherein one of R g and R h is a saccharide, and the other R g and R h is OH.

16. The method of claim 11 , wherein the substituent is a substituent of formula IV:

wherein one of R m and R n is a saccharide, and the other is OH.

17. The method of claim 11 , wherein the substituent is a substituent of formula (i):

18. The method of claim 11 , wherein the substituent is a substituent of formula (ii):

19. The method of claim 11 , wherein the substituent is a substituent of formula (iii):

20. The method of claim 11 , wherein the substituent is a substituent of formula (iv):

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033181/0624 →